14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.10 $80.02 Wednesday, 8th May 2024 ARWR stock ended at $25.22. This is 0.88% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 3.99% from a day low at $24.30 to a day high of $25.27.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Nov 22, 2016 $4.39 $4.56 $4.37 $4.44 1 891 204
Nov 21, 2016 $4.44 $4.47 $4.22 $4.35 1 303 257
Nov 18, 2016 $4.55 $4.61 $4.40 $4.42 878 064
Nov 17, 2016 $4.45 $4.59 $4.39 $4.51 684 155
Nov 16, 2016 $4.73 $5.01 $4.40 $4.44 1 593 250
Nov 15, 2016 $4.44 $4.77 $4.38 $4.73 985 708
Nov 14, 2016 $4.25 $4.55 $4.25 $4.42 1 882 308
Nov 11, 2016 $4.40 $4.56 $4.14 $4.18 2 398 819
Nov 10, 2016 $4.24 $4.34 $4.09 $4.30 2 313 279
Nov 09, 2016 $4.82 $5.50 $4.15 $4.20 6 453 783
Nov 08, 2016 $6.11 $6.11 $6.11 $6.11 765 483
Nov 07, 2016 $5.78 $6.04 $5.68 $5.87 710 900
Nov 04, 2016 $5.55 $5.75 $5.55 $5.68 605 400
Nov 03, 2016 $5.89 $5.90 $5.56 $5.58 756 200
Nov 02, 2016 $6.03 $6.06 $5.83 $5.84 589 000
Nov 01, 2016 $5.80 $6.04 $5.77 $6.02 590 800
Oct 31, 2016 $5.83 $5.93 $5.64 $5.80 463 700
Oct 28, 2016 $6.00 $6.08 $5.80 $5.87 621 300
Oct 27, 2016 $6.15 $6.28 $6.00 $6.04 452 100
Oct 26, 2016 $6.28 $6.44 $6.13 $6.15 480 900
Oct 25, 2016 $6.51 $6.59 $6.30 $6.33 388 700
Oct 24, 2016 $6.72 $6.76 $6.52 $6.56 363 300
Oct 21, 2016 $6.76 $6.86 $6.68 $6.70 324 900
Oct 20, 2016 $6.60 $6.85 $6.60 $6.83 615 900
Oct 19, 2016 $6.64 $6.73 $6.52 $6.65 383 000
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT